The partnership aims to provide sponsors and researchers with a complete solution for disclosure and data sharing.

TrialScope adopts a SaaS-based, centralised method for the disclosure and transparency of clinical trials. This approach has been used by multiple pharmaceutical companies of different sizes.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The alliance with Vivli is expected to help TrialScope deliver a comprehensive platform for disclosure and data sharing.

TrialScope CEO Jeff Kozloff said: “There is a growing trend towards increased transparency within the clinical trial industry, not just to meet regulatory requirements, but as an ethical obligation to advance science and promote patient safety.

“We appreciate the fact that Vivli is disease agnostic and can synthesise data from multiple repositories, which will greatly reduce duplication of clinical trials, putting fewer patients through studies unnecessarily.”

Under the collaboration, the partners will combine their respective expertise to offer disclosure and data sharing software and advisory services.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

In addition, TrialScope and Vivli intend to provide a technology that will help in finding clinical trial information online. The companies will also deliver end-to-end workflow support for managing data-sharing requests.

Vivli executive director Rebecca Li said: “Together, we offer an end-to-end solution. There is simply no complete solution for researchers and sponsors alike, who want to spend less time searching for previous data, and more time on advancing science.”

Launched last year, Vivli portfolio includes a data sharing platform that currently has more than 3,200 trials across 100 different countries.